Shield T3 Revenue and Competitors
Estimated Revenue & Valuation
- Shield T3's estimated annual revenue is currently $23.8M per year.
- Shield T3's estimated revenue per employee is $270,000
Employee Data
- Shield T3 has 88 Employees.
- Shield T3 grew their employee count by 9% last year.
Shield T3's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Operating Officer | Reveal Email/Phone |
3 | Chief Scientific Officer and Head R&D | Reveal Email/Phone |
4 | Chief Compliance Officer, VP | Reveal Email/Phone |
5 | Chief Financial Officer | Reveal Email/Phone |
6 | VP | Reveal Email/Phone |
7 | Director Business Development | Reveal Email/Phone |
8 | Director Operations, Health & Wellness | Reveal Email/Phone |
9 | Director Technical Sales - Wastewater Business Unit | Reveal Email/Phone |
10 | Sales Director – Wastewater | Reveal Email/Phone |
Shield T3 Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $54.4M | 183 | 6% | N/A | N/A |
#2 | $18M | 74 | -4% | N/A | N/A |
#3 | $162.7M | 482 | 39% | N/A | N/A |
#4 | $42.8M | 144 | 8% | N/A | N/A |
#5 | $26.5M | 98 | 4% | N/A | N/A |
#6 | $33.2M | 123 | -2% | N/A | N/A |
#7 | $29.7M | 110 | 12% | N/A | N/A |
#8 | $15.5M | 66 | -21% | $29.7M | N/A |
#9 | $1645.8M | 4354 | 13% | N/A | N/A |
#10 | $43.7M | 147 | 18% | N/A | N/A |
What Is Shield T3?
N/A
Total Funding
88
Number of Employees
$23.8M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Shield T3 News
2022-03-22 - New COVID Spit Tests May Be More Accurate and Easier Than Nasal Swabs
SHIELD T3, a spinoff company owned by the University of Illinois System, recently started producing covidSHIELD self-collection kits that...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $15M | 88 | -16% | $31.2M |
#2 | $7.5M | 88 | 6% | N/A |
#3 | $3.5M | 88 | 9% | N/A |
#4 | $29M | 88 | -2% | N/A |
#5 | $11.9M | 88 | 17% | N/A |